Call of the squash

Lacayote squash Credit: Courtesy of Thomas Andres" />Lacayote squash Credit: Courtesy of Thomas Andres Last fall, Thomas Andres was wandering around New York City's Chinatown when he happened upon the subject of his doctoral dissertation: the lacayote, Cucurbita ficifolia, a South American squash rarely sold in the United States. He was happy to shell out $6 for the mottled green gourd. Twenty-five years ago, he had dreamed of discovering its wild ancestor on some scrubby hillside in

Written byBrendan Borrell
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Last fall, Thomas Andres was wandering around New York City's Chinatown when he happened upon the subject of his doctoral dissertation: the lacayote, Cucurbita ficifolia, a South American squash rarely sold in the United States. He was happy to shell out $6 for the mottled green gourd. Twenty-five years ago, he had dreamed of discovering its wild ancestor on some scrubby hillside in Mexico. Because centuries of inbreeding have reduced the genetic diversity of many domesticated crops, finding their natural populations could help scientists identify beneficial genes which could eventually improve crop lines. Unfortunately, the lacayote's wild ancestor never turned up, and Andres never quite finished his PhD.

Apart from a thinning of the hair and a slight bulge at the belly, Andres, 53, still looks the part of a graduate student. He brought his lacayote to fellow squash enthusiast Michael Nee at the New York Botanical Garden in the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies